Page 44 - 79_03

J.
C.
Rodríguez
Rey

7. Randle,
P.J.,
Garland,
P.B.,
Hales,
C.N.,
and
Newsholme,
E.A.
1963.
The
glucose
fatty-­-acid

cycle.
Its
role
in
insulin
sensitivity
and
the
metabolic
disturbances
of
diabetes
mellitus.

Lancet
1:785-­-789.

8. Hue,
L.,
and
Taegtmeyer,
H.
2009.
The
Randle
cycle
revisited:
a
new
head
for
an
old
hat.

Am
J
Physiol
Endocrinol
Metab
297:E578-­-591.

9. Jucker,
B.M.,
Rennings,
A.J.,
Cline,
G.W.,
and
Shulman,
G.I.
1997.
13C
and
31P
NMR
studies

on
the
effects
of
increased
plasma
free
fatty
acids
on
intramuscular
glucose
metabolism
in

the
awake
rat.
J
Biol
Chem
272:10464-­-10473.

10. Saha,
A.K.,
Schwarsin,
A.J.,
Roduit,
R.,
Masse,
F.,
Kaushik,
V.,
Tornheim,
K.,
Prentki,
M.,
and

Ruderman,
N.B.
2000.
Activation
of
malonyl-­-CoA
decarboxylase
in
rat
skeletal
muscle
by

contraction
and
the
AMP-­-activated
protein
kinase
activator
5-­-aminoimidazole-­-4-­-
carboxamide-­-1-­-beta
-­-D-­-ribofuranoside.
J
Biol
Chem
275:24279-­-24283.

11. Riancho,
J.A.,
Vazquez,
L.,
Garcia-­-Perez,
M.A.,
Sainz,
J.,
Olmos,
J.M.,
Hernandez,
J.L.,
Perez-­-
Lopez,
J.,
Amado,
J.A.,
Zarrabeitia,
M.T.,
Cano,
A.,
et
al.
2011.
Association
of
ACACB

polymorphisms
with
obesity
and
diabetes.
Mol
Genet
Metab
104:670-­-676.

12. McGarry,
J.D.
2002.
Banting
lecture
2001:
dysregulation
of
fatty
acid
metabolism
in
the

etiology
of
type
2
diabetes.
Diabetes
51:7-­-18.

13. Rothman,
D.L.,
Magnusson,
I.,
Cline,
G.,
Gerard,
D.,
Kahn,
C.R.,
Shulman,
R.G.,
and
Shulman,

G.I.
1995.
Decreased
muscle
glucose
transport/phosphorylation
is
an
early
defect
in
the

pathogenesis
of
non-­-insulin-­-dependent
diabetes
mellitus.
Proc
Natl
Acad
Sci
U
S
A
92:983-­-
987.

14. Rothman,
D.L.,
Shulman,
R.G.,
and
Shulman,
G.I.
1992.
31P
nuclear
magnetic
resonance

measurements
of
muscle
glucose-­-6-­-phosphate.
Evidence
for
reduced
insulin-­-dependent

muscle
glucose
transport
or
phosphorylation
activity
in
non-­-insulin-­-dependent
diabetes

mellitus.
J
Clin
Invest
89:1069-­-1075.

15. Shulman,
G.I.,
Rothman,
D.L.,
Jue,
T.,
Stein,
P.,
DeFronzo,
R.A.,
and
Shulman,
R.G.
1990.

Quantitation
of
muscle
glycogen
synthesis
in
normal
subjects
and
subjects
with
non-­-
insulin-­-dependent
diabetes
by
13C
nuclear
magnetic
resonance
spectroscopy.
N
Engl
J

Med
322:223-­-228.

16. Brechtel,
K.,
Dahl,
D.B.,
Machann,
J.,
Bachmann,
O.P.,
Wenzel,
I.,
Maier,
T.,
Claussen,
C.D.,

Haring,
H.U.,
Jacob,
S.,
and
Schick,
F.
2001.
Fast
elevation
of
the
intramyocellular
lipid

content
in
the
presence
of
circulating
free
fatty
acids
and
hyperinsulinemia:
a
dynamic
1H-­-
MRS
study.
Magn
Reson
Med
45:179-­-183.

17. Roden,
M.,
Price,
T.B.,
Perseghin,
G.,
Petersen,
K.F.,
Rothman,
D.L.,
Cline,
G.W.,
and
Shulman,

G.I.
1996.
Mechanism
of
free
fatty
acid-­-induced
insulin
resistance
in
humans.
J
Clin
Invest

97:2859-­-2865.

18. Cline,
G.W.,
Petersen,
K.F.,
Krssak,
M.,
Shen,
J.,
Hundal,
R.S.,
Trajanoski,
Z.,
Inzucchi,
S.,

Dresner,
A.,
Rothman,
D.L.,
and
Shulman,
G.I.
1999.
Impaired
glucose
transport
as
a
cause

of
decreased
insulin-­-stimulated
muscle
glycogen
synthesis
in
type
2
diabetes.
N
Engl
J
Med

341:240-­-246.

19. McCarthy,
M.I.
2010.
Genomics,
type
2
diabetes,
and
obesity.
N
Engl
J
Med
363:2339-­-2350.

20. Watson,
R.T.,
and
Pessin,
J.E.
2006.
Bridging
the
GAP
between
insulin
signaling
and
GLUT4

translocation.
Trends
Biochem
Sci
31:215-­-222.

21. Watson,
R.T.,
Kanzaki,
M.,
and
Pessin,
J.E.
2004.
Regulated
membrane
trafficking
of
the

insulin-­-responsive
glucose
transporter
4
in
adipocytes.
Endocr
Rev
25:177-­-204.

22. Sun,
X.J.,
Rothenberg,
P.,
Kahn,
C.R.,
Backer,
J.M.,
Araki,
E.,
Wilden,
P.A.,
Cahill,
D.A.,

Goldstein,
B.J.,
and
White,
M.F.
1991.
Structure
of
the
insulin
receptor
substrate
IRS-­-1

defines
a
unique
signal
transduction
protein.
Nature
352:73-­-77.

23. White,
M.F.
2002.
IRS
proteins
and
the
common
path
to
diabetes.
Am
J
Physiol
Endocrinol

Metab
283:E413-­-422.

429